|
| 36707090 | SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report. | J Immunother Cancer | 2023 |
| 36399695 | Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial. | J Clin Oncol | 2023 |
| 37217509 | Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia. | Nat Commun | 2023 |
| 37024595 | Tumor inflammation-associated neurotoxicity. | Nat Med | 2023 |
| 36707090 | SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report. | J Immunother Cancer | 2023 |
| 36625902 | Single-cell technologies uncover intra-tumor heterogeneity in childhood cancers. | Semin Immunopathol | 2023 |
| 37428431 | Early brace treatment for idiopathic scoliosis may change the paradigm to improve curves. | Spine Deform | 2023 |
| 36849202 | Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD. | J Immunother Cancer | 2023 |
| 37481326 | Advances in Clinical Mass Cytometry. | Clin Lab Med | 2023 |
| 37351311 | tidytof: a user-friendly framework for scalable and reproducible high-dimensional cytometry data analysis. | Bioinform Adv | 2023 |
| 37162847 | Inosine Induces Stemness Features in CAR T cells and Enhances Potency. | bioRxiv | 2023 |
| 37481326 | Advances in Clinical Mass Cytometry. | Clin Lab Med | 2023 |
| 37024595 | Tumor inflammation-associated neurotoxicity. | Nat Med | 2023 |
| 37351311 | tidytof: a user-friendly framework for scalable and reproducible high-dimensional cytometry data analysis. | Bioinform Adv | 2023 |
| 37217509 | Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia. | Nat Commun | 2023 |
| 37428431 | Early brace treatment for idiopathic scoliosis may change the paradigm to improve curves. | Spine Deform | 2023 |
| 37162847 | Inosine Induces Stemness Features in CAR T cells and Enhances Potency. | bioRxiv | 2023 |
| 36625902 | Single-cell technologies uncover intra-tumor heterogeneity in childhood cancers. | Semin Immunopathol | 2023 |
| 36849202 | Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD. | J Immunother Cancer | 2023 |
| 36399695 | Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial. | J Clin Oncol | 2023 |
| 35079114 | Understanding the hematopoietic factory during acute lymphoblastic leukemia. | Pediatr Res | 2022 |
| 35580293 | Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again. | Am Soc Clin Oncol Educ Book | 2022 |
| 36190525 | A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412. | Clin Cancer Res | 2022 |
| 36523979 | Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patients. | Front Oncol | 2022 |
| 35130560 | GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. | Nature | 2022 |
| 35115489 | An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia. | Nat Commun | 2022 |
| 35079114 | Understanding the hematopoietic factory during acute lymphoblastic leukemia. | Pediatr Res | 2022 |
| 35177627 | CytofIn enables integrated analysis of public mass cytometry datasets using generalized anchors. | Nat Commun | 2022 |
| 35580293 | Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again. | Am Soc Clin Oncol Educ Book | 2022 |
| 36523979 | Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patients. | Front Oncol | 2022 |
| 36190525 | A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412. | Clin Cancer Res | 2022 |
| 35130560 | GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. | Nature | 2022 |
| 35177627 | CytofIn enables integrated analysis of public mass cytometry datasets using generalized anchors. | Nat Commun | 2022 |
| 35115489 | An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia. | Nat Commun | 2022 |
| 33355997 | Use of cardiac radiation therapy as bridging therapy to CAR-T for relapsed pediatric B-cell acute lymphoblastic leukemia. | Pediatr Blood Cancer | 2021 |
| 33512414 | CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphoma. | Blood | 2021 |
| 34312556 | CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. | Nat Med | 2021 |
| 33355997 | Use of cardiac radiation therapy as bridging therapy to CAR-T for relapsed pediatric B-cell acute lymphoblastic leukemia. | Pediatr Blood Cancer | 2021 |
| 33165843 | Mass Cytometry of Hematopoietic Cells. | Methods Mol Biol | 2021 |
| 34428097 | Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer. | JCO Clin Cancer Inform | 2021 |
| 34944883 | Comparison of the Transcriptomic Signatures in Pediatric and Adult CML. | Cancers (Basel) | 2021 |
| 33512414 | CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphoma. | Blood | 2021 |
| 34944883 | Comparison of the Transcriptomic Signatures in Pediatric and Adult CML. | Cancers (Basel) | 2021 |
| 34428097 | Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer. | JCO Clin Cancer Inform | 2021 |
| 34312556 | CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. | Nat Med | 2021 |
| 33165843 | Mass Cytometry of Hematopoietic Cells. | Methods Mol Biol | 2021 |
| 32192573 | Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial. | Lancet Oncol | 2020 |
| 32192573 | Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial. | Lancet Oncol | 2020 |
| 31997022 | Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia. | Curr Oncol Rep | 2020 |
| 32106308 | Supercharging your CAR. | Blood | 2020 |